Title {1}	Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts
Trial registration {2a and 2b}.	NCT04333485 [ClinicalTrials.gov], Registered April 3, 2020 CTRI/2020/05/025059 [Clinical Trials Registry of India], registered May 6 2020.
Protocol version {3}	Version 1.3, January 28, 2022
Funding {4}	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), R01AI143748
Author details {5a}	1. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA 2. Johns Hopkins School of Medicine, Baltimore, MD, USA 3. Johns Hopkins India, Pune, Maharashtra, India 4. George Washington University, Washington, D.C., USA 5. Dr. D.Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India 6. Seoul National University College of Medicine, Seoul, Republic of Korea
Name and contact information for the trial sponsor {5b}.	Karen A Lacourciere, NIH/NIAID Program Officer, lacourcierek@niaid.nih.gov
Role of sponsor {5c}	The sponsor had no role in the study design or writing of this manuscript.